Glioblastoma is the most common – and the most malignant – primary brain tumour in adults. It’s aggressive and incurable. Even with treatment...
Vous n'êtes pas connecté
Researchers from the Ural Federal University (UrFU), in collaboration with other Russian colleagues, have synthesized a compound with anti-tumor properties that could form the basis of a drug to treat glioblastoma – an aggressive and malignant tumor of the central nervous system.
Glioblastoma is the most common – and the most malignant – primary brain tumour in adults. It’s aggressive and incurable. Even with treatment...
A new imaging technique could mean patients with aggressive brain tumours benefit from cutting-edge immunotherapy treatments, according to...
Newly discovered targets may hold the key to effectively treating glioblastoma, a deadly form of brain cancer. These targets were identified by...
Scientists from Yale and other institutions have discovered that tirzepatide, a drug approved to treat type 2 diabetes, may also be highly effective...
Researchers at Uppsala University and KTH Royal Institute of Technology have developed a new form of precision medicine, an antibody, with the...
Scientists have discovered a way to target elusive circular fragments of DNA that drive the survival of some of the most aggressive cancers, paving...
Researchers at Helmholtz Munich, in collaboration with colleagues at Tohoku University, have identified a specific redox protein as a critical...
Researchers at Baylor College of Medicine and Washington University School of Medicine in St. Louis, USA, have identified clinical and genetic...
Want to prevent glioblastoma? By applying new techniques like CRISPR/Cas9 screens, scientists have identified new targets for treating glioblastoma,...
THURSDAY, Nov. 14, 2024 -- An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast...